Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
prostate cancer
Pharma
Novartis' Pluvicto slows progression in earlier prostate cancer
Novartis also reported an early positive trend in overall survival, although that data point remained immature.
Angus Liuu
Oct 19, 2025 10:30am
ClevelandDx reboots campaign to drive prostate cancer screening
Aug 27, 2025 9:30am
Novartis' Pluvicto picks up speed, delivers another trial win
Jul 17, 2025 10:56am
Pfizer, Astellas' Xtandi combo extends life in early prostate cancer
Jul 10, 2025 11:52am
FDA approves use of Bayer's Nubeqa in all patients with mCSPC
Jun 4, 2025 11:38am
J&J PARP path unclear in castration-sensitive prostate cancer subset
Jun 3, 2025 8:00am
